Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells

被引:43
作者
Pullarkat, V
Roy, L
Lee, SM
Bender, JG
Weber, JS
机构
[1] Univ So Calif, Norris Canc Ctr, Div Hematol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Med, Div Oncol, Los Angeles, CA USA
[3] Nexell Therapeut, Irvine, CA USA
关键词
dendritic cells; monocyte enrichment; bag culture; immune response;
D O I
10.1016/S0022-1759(02)00181-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Conventional methods for generating monocyte-derived dendritic cells (DC) for clinical trials utilize (he property of plastic adherence to select monocytes from leukapheresis samples. This method is labor-intensive and has the potential for contamination at various steps. We evaluated a large-scale monocyte enrichment procedure using a cell selector (Isolex 300i(R),) followed by culture in a sterile bag system (Stericell(R)) for generation of DC. DC generated in tissue culture flasks after monocyte selection by plastic adherence were compared to those generated in Stericell(R) bags after monocyte enrichment by negative selection with the Isolex(R) 300i. DC were matured with lipopolysaccharide and pulsed with a peptide derived from the melanoma antigen gp100. Peptide-pulsed DC cultured by the two techniques were evaluated for phenotype, viability, ability to induce allogeneic and peptide-specific autologous proliferative responses as well as peptide-specific cytotoxic T-cell responses. The mean monocyte yield from leukapheresis collections was 17 +/- 2.4%, which increased to 52 +/- 11% after Isolex(R) selection. The DC yield of plated monotruclear cells from flasks or bags was 2,7 +/- 0.96% and 4,84 +/- 2.65%, respectively. DC cultured by both methods expressed high levels of CD86, CD80, CD40, CD83, CD44, CD11c and CD58, and was comparable in their ability to induce allogeneic and peptide-specific autologous proliferative responses as well as gp100 peptide-specific cytotoxic T-cell responses. These results indicate that potent monocyte-derived DC can be generated in a closed culture bag system after monocyte enrichment by immunomagnetic negative selection. Due to the closed nature of the enrichment and culture systems, the potential for contamination is minimized. This protocol is well suited for culturing large numbers of DC for clinical immunotherapy trials. (C) 2002 Elsevier Science B.V.. All rights reserved.
引用
收藏
页码:173 / 183
页数:11
相关论文
共 26 条
[1]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[2]  
Bernard J, 1998, HEMATOL CELL THER, V40, P17
[3]   A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts [J].
Björkstrand, B ;
Sundman-Engberg, B ;
Christensson, B ;
Kumlien, G .
JOURNAL OF HEMATOTHERAPY, 1999, 8 (01) :75-80
[4]   In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy [J].
Cao, H ;
Vergé, V ;
Baron, C ;
Martinache, C ;
Leon, A ;
Scholl, S ;
Gorin, NC ;
Salamero, J ;
Assari, S ;
Bernard, J ;
Lopez, M .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (02) :183-194
[5]   Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements [J].
Duperrier, K ;
Eljaafari, A ;
Dezutter-Dambuyant, C ;
Bardin, C ;
Jacquet, C ;
Yoneda, K ;
Schmitt, D ;
Gebuhrer, L ;
Rigal, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 238 (1-2) :119-131
[6]   In vitro production of dendritic cells from human blood monocytes for therapeutic use [J].
Garderet, L ;
Cao, H ;
Salamero, J ;
Vergé, V ;
Tisserand, E ;
Scholl, S ;
Gorin, NC ;
Lopez, M .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (04) :553-567
[7]   MODULATION OF T-CELL PRODUCTION OF INTERFERON-GAMMA BY HUMAN MONOCYTES - EFFECT OF ENGAGEMENT OF CD14 ON MONOCYTES [J].
HIROHATA, S ;
OKA, H .
CELLULAR IMMUNOLOGY, 1993, 151 (02) :270-282
[8]   Ex vivo generation of dendritic cells from CD34+ cells in gas-permeable containers under serum-free conditions [J].
Kowalkowski, KL ;
Alzona, MT ;
Aono, FM ;
Van Epps, DE ;
Vachula, M .
JOURNAL OF HEMATOTHERAPY, 1998, 7 (05) :403-411
[9]   RETRACTED: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids (Retracted article. See vol. 9, p. 1221, 2003) [J].
Kugler, A ;
Stuhler, G ;
Walden, P ;
Zöller, G ;
Zobywalski, A ;
Brossart, P ;
Trefzer, U ;
Ullrich, S ;
Müller, CA ;
Becker, V ;
Gross, AJ ;
Hemmerlein, B ;
Kanz, L ;
Müller, GA ;
Ringert, RH .
NATURE MEDICINE, 2000, 6 (03) :332-336
[10]  
LEE S, 2000, P AM ASSOC CANC RES, V41, P520